Albert Irkaliev։ Could Pacemaker-Like Cells Influence Embryo Implantation?
Albert Irkaliev, Reproductologist at SILK Medical, shared on LinkedIn:
“The Uterus Is Not a Passive Organ: Could Pacemaker-Like Cells Influence Embryo Implantation?
In IVF, implantation is usually discussed in terms of embryo competence and endometrial receptivity.
But there may be a third component: uterine dynamics.
The uterus is not a passive cavity. Throughout the menstrual cycle, the myometrium and junctional zone demonstrate coordinated contractile activity – uterine peristalsis – which changes with hormonal conditions.
One intriguing area of research involves interstitial Cajal-like cells (ICLCs), often described as telocytes, identified in the human uterus.
These cells form extensive networks and interact with smooth muscle, nerves, and blood vessels. Because of their similarities to the interstitial cells of Cajal – the established pacemaker cells of the gastrointestinal tract – researchers have investigated whether they might contribute to the coordination of uterine contractility.
However, their role as true uterine pacemaker cells remains unproven.
Why could this matter in IVF?
After ovulation, progesterone is associated with reduced uterine contractility, creating a relatively quiet mechanical environment around implantation.
Studies have also reported associations between increased uterine contractions around embryo transfer and lower implantation or pregnancy rates.
This does not mean that uterine contractions cause implantation failure. Nor is ՛telocyte dysfunction՛ currently a clinical diagnosis.
But it raises an interesting concept: embryo transfer occurs in a dynamic muscular organ – not in a static cavity.
Implantation may therefore depend not only on:
- Embryo + Endometrium
but potentially also on:
- Embryo + Endometrium + Uterine Dynamics
Altered uterine contractility has been investigated in conditions such as adenomyosis, endometriosis, fibroids and junctional-zone abnormalities.
At present, there is no validated clinical test for telocyte dysfunction and no established telocyte-targeted IVF treatment.
But understanding uterine cellular, electrical, and mechanical behavior may eventually add another dimension to implantation biology.
The uterus may not simply be the place where implantation occurs. It may be an active participant in how implantation occurs.”

Other articles featuring Albert Irkaliev on Fertility News.
-
Nov 22, 2026, 17:01Insights from ISFP 2026
-
Nov 22, 2026, 16:17Khalil Faaed: The Dark Center of the Oocyte
-
Nov 22, 2026, 16:10Jyoti Gupta: Proud to Join Cloudnine Fertility, Golf Course Road, Gurugram, as Director
-
Nov 22, 2026, 15:45Francine Freitas Fernandes: 3D and 4D Hysterosalpingo-Contrast Sonography
-
Nov 22, 2026, 15:25New RBMO Study Links Microfluidic Sperm Sorting to Higher Blastocyst Formation and Lower Miscarriage Rates
-
Nov 22, 2026, 15:21Michelle Mason: Pleased to Attend the Annual SWIGS Conference with the Care Fertility Cardiff Team
-
Nov 22, 2026, 15:18Rajeev Agarwal: The Lining Is 6.5 mm – Will the Embryo Transfer Fail?
-
Nov 22, 2026, 15:11The Automated IVF Laboratory Lecture by Jacques Cohen at the 5th Narture – Conceivable Life Sciences
-
Nov 22, 2026, 15:07Laura Rienzi: Same Message, 2 Slides – Which One Would You Rather See at a Congress?
